Table 3

Linear correlation between endothelial parameters with life time alcohol consumption, years of drinking, levels of serum enzymes, level of MCV, screening questionnaires and stages of fatty liver on endothelial parameters in ADS group

CCT, µmCV, %CD, cells/mm2 Hexa, %
Lifetime alcoholSpearman’s correlation coefficient (ρ)−0.035−0.0370.0020.037
P value0.6680.6510.9840.646
Number of patients155155155155
Years of drinkingSpearman’s correlation coefficient (ρ)−0.033−0.143−0.0080.191
P value0.6780.0750.9170.016*
Number of patients157157157157
GGTSpearman’s correlation coefficient (ρ)−0.023−0.143−0.1070.185
P value0.7730.0710.1780.019*
Number of patients160160160160
ALTSpearman’s correlation coefficient (ρ)0.0510.024−0.1220.042
P value0.5190.7680.1240.600
Number of patients160160160160
ASTSpearman’s correlation coefficient (ρ)0.049−0.045−0.1450.060
P value0.5390.5750.0670.452
Number of patients160160160160
MCVSpearman’s correlation coefficient (ρ)0.0400.1380.066−0.094
P value0.6170.0820.4070.239
Number of patients159159159159
AUDITSpearman’s correlation coefficient (ρ)0.0570.043−0.002−0.062
P value0.4750.5930.9850.438
Number of patients160160160160
ASISpearman’s correlation coefficient (ρ)−0.0850.0700.015−0.118
P value0.2850.3840.8550.137
Number of patients159159159159
  • *Significant (P<0.05).

  • ADS,  alcohol dependence syndrome; ALT, alanine amino-transferase; ASI, Addiction Severity Index; AST, aspartate amino-transferase; AUDIT, Alcohol Use Disorder Identification Test; CCT, central corneal thickness; CD,  cell density; CV,  coefficient of variation; GGT, gamma glutamyl transferase; MCV, mean  corpuscular  volume.